Revenue Growth Expectations -- With an organization that is realigned to meet the growth challenges ahead, an enhanced product line, significantly increased user acceptance of ActiPatch and a booming international distribution channel, we are expecting significant revenue growth for the rest of 2008 and into 2009.
While it would be inappropriate to comment specifically on the first quarter first revenue results until we make a public announcement, we do believe it is appropriate to give our investors some information relating to the strong level of revenue growth we are experiencing. For example, during the month of April we produced more revenue than in the entire first quarter. We are expecting sales in May to outpace those of April and June to outpace May. Additionally, based on our current and expected order backlogs, it appears we will continue to ramp sales each month moving forward through 2008.
For the past couple of years as we developed our product line and our distribution channels we were faced with the normal issues that face most development stage companies -- product development, sales force organization, market acceptance, etc. -- these problems have largely evaporated. We are currently facing a new set of problems, which are the kind of problems that most companies like to have at this stage of development -- meeting the growing demand. Meeting this developing demand presents a different set of challenges for the company, but we believe we are prepared to meet these challenges.
For all of us at BioElectronics, the company is much more than about
simply expanding sales and producing profits, although of course this is
our major goal, but it is also about bringing a revolutionary technology to
the market that we believe truly reduces pain and suffering for many
|SOURCE BioElectronics Corporation|
Copyright©2008 PR Newswire.
All rights reserved